INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Larimar Therapeutics, Inc. – LRMR
NEW YORK, NY, NY / ACCESS Newswire / October 21, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Larimar Therapeutics, Inc.("Larimar" or the "Company") (NASDAQ:LRMR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Larimar and certain of its officers and/or directors […]